KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Assets (2016 - 2025)

Historic Return on Assets for Vertex Pharmaceuticals (VRTX) over the last 16 years, with Q3 2025 value amounting to 0.15%.

  • Vertex Pharmaceuticals' Return on Assets rose 1700.0% to 0.15% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15%, marking a year-over-year increase of 1700.0%. This contributed to the annual value of 0.02% for FY2024, which is 2000.0% down from last year.
  • Latest data reveals that Vertex Pharmaceuticals reported Return on Assets of 0.15% as of Q3 2025, which was up 1700.0% from 0.16% recorded in Q2 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Assets peaked at 0.23% during Q1 2021, and registered a low of 0.04% during Q1 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' median Return on Assets value was 0.17% (recorded in 2023), while the average stood at 0.14%.
  • Data for Vertex Pharmaceuticals' Return on Assets shows a peak YoY increase of 1800bps (in 2025) and a maximum YoY decrease of -2200bps (in 2025) over the last 5 years.
  • Over the past 5 years, Vertex Pharmaceuticals' Return on Assets (Quarter) stood at 0.18% in 2021, then grew by 6bps to 0.19% in 2022, then decreased by -15bps to 0.16% in 2023, then crashed by -115bps to 0.02% in 2024, then surged by 728bps to 0.15% in 2025.
  • Its last three reported values are 0.15% in Q3 2025, 0.16% for Q2 2025, and 0.04% during Q1 2025.